Collegium Pharmaceutical, Inc. (NASDAQ:) swing trade worked out really well. I gave it to you in the 10 1/2 range, immediately ripped and didn’t stop until Monday, popping 52 cents, or 3.69%, to 14.61, on 1.5 million shares traded. it reached my first target at 13 1/2. My next target is 17. At this point, I’m not sure it will get to 17, so let’s make it 16 1/2 first. It might pull back and consolidate, and if it does, it’s going to be a set up.
Mirati Therapeutics, Inc. (NASDAQ:) is one of our swing trades that is acting well. It held support, and moved up 45 cents, or 3%, to 15.50, on 390,538 shares traded on Monday. It’s now testing resistance at 16 1/2, my target. At this point, it looks like it’s going to 20.
What a swing Nektar Therapeutics (NASDAQ:) has been. In about a week, it went from 23.00 to 41.00. Up 18 points. On Monday, it closed up 4.60, or 14%, to 37.10, on 17.4 million shares traded. The bottom line is that it hit resistance right at the zone at the top of the channel, and it’s way overbought, and it did come down off the high. Let’s see if it backs and fills, and consolidates before it goes higher. It has 12.7 days to cover .
Overstock.com, Inc. (NASDAQ:) just keeps going. On Monday, it ran 3.15, or 6%, to 56.30, on 3.7 million shares traded and reached the top of the channel my target in the mid 50’s. That doesn’t mean it can’t accelerate and get to 65, or even 75. Those are the targets going forward.
On the long side, stocks included ADAMS, BioLife Solutions, Inc. (NASDAQ:), Concert Pharmaceuticals, Inc. (NASDAQ:), Collegium Pharmaceutical, Inc. (NASDAQ:), Forterra, Inc. (NASDAQ:), Helios and Matheson Analytics Inc. (NASDAQ:), Mirati Therapeutics, Inc. (NASDAQ:), MagnaChip Semiconductor Corporation (NYSE:), Nektar Therapeutics (NASDAQ:), Ophthotech Corporation (NASDAQ:), Overstock.com, Inc. (NASDAQ:), Roku, Inc. (NASDAQ:), Trupanion, Inc. (NASDAQ:), TransEnterix, Inc. (NYSE:), USA Technologies, Inc. (NASDAQ:), 58.com Inc. (NYSE:).